HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Premkumar Reddy Selected Research

ON013100

3/2013Determination of the glucuronide metabolite of ON 013100, a benzylstyrylsulfone antineoplastic drug, in colon cancer cells using LC/MS/MS.
9/2012Preclinical pharmacokinetic and pharmacodynamic evaluation of novel anticancer agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for brain tumor chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Premkumar Reddy Research Topics

Disease

33Neoplasms (Cancer)
01/2021 - 01/2002
5Carcinogenesis
09/2017 - 05/2005
5Brain Neoplasms (Brain Tumor)
05/2014 - 12/2011
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2014 - 02/2005
3Melanoma (Melanoma, Malignant)
01/2021 - 01/2002
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2018 - 01/2013
3Carcinoma (Carcinomatosis)
04/2014 - 10/2004
2Breast Neoplasms (Breast Cancer)
01/2021 - 09/2011
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2018 - 03/2013
2Leukemia
12/2018 - 02/2005
2Prostatic Neoplasms (Prostate Cancer)
01/2018 - 07/2011
2Glioma (Gliomas)
05/2014 - 09/2012
2Lymphoma (Lymphomas)
03/2013 - 07/2011
2Colonic Neoplasms (Colon Cancer)
03/2013 - 05/2005
1Parkinson Disease (Parkinson's Disease)
12/2021
1Alzheimer Disease (Alzheimer's Disease)
12/2021
1Huntington Disease (Huntington's Disease)
12/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021
1Neuroblastoma
12/2021
1Triple Negative Breast Neoplasms
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2018
1Hematologic Neoplasms (Hematological Malignancy)
12/2018
1Ovarian Neoplasms (Ovarian Cancer)
11/2016
1Multiple Myeloma
03/2016
1Retinoblastoma (Glioblastoma, Retinal)
01/2016
1Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2014
1Adenoma (Adenomas)
09/2012
1Polyps
09/2012
1Sarcoma (Soft Tissue Sarcoma)
09/2012
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2011
1Liver Neoplasms (Liver Cancer)
05/2011
1Beckwith-Wiedemann Syndrome (Exomphalos Macroglossia Gigantism Syndrome)
11/2010
1Myeloproliferative Disorders (Myeloproliferative Disorder)
10/2010
1Nevi and Melanomas
08/2010

Drug/Important Bio-Agent (IBA)

14Phosphotransferases (Kinase)IBA
12/2018 - 01/2002
13Proteins (Proteins, Gene)FDA Link
12/2021 - 05/2005
8Pharmaceutical PreparationsIBA
12/2021 - 04/2010
7ON 01910IBA
01/2020 - 03/2005
7Antineoplastic Agents (Antineoplastics)IBA
07/2013 - 07/2011
5Imatinib Mesylate (Gleevec)FDA Link
02/2014 - 02/2005
3SulfonesIBA
01/2020 - 07/2011
3Cyclin D1IBA
12/2018 - 11/2005
3Adenosine Triphosphate (ATP)IBA
12/2018 - 04/2010
3ON123300IBA
03/2016 - 05/2014
3Transforming Growth Factor beta (TGF-beta)IBA
05/2011 - 05/2005
3Cyclin-Dependent Kinase 4IBA
05/2011 - 11/2005
2ON013100IBA
03/2013 - 09/2012
2SpectrinIBA
11/2010 - 05/2005
2Protein Isoforms (Isoforms)IBA
11/2010 - 02/2005
2CytokinesIBA
10/2010 - 12/2002
2CarcinogensIBA
08/2010 - 01/2002
2Cyclin-Dependent Kinase Inhibitor p16IBA
05/2007 - 01/2002
1phenserineIBA
12/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1dabrafenibIBA
01/2021
1Therapeutic UsesIBA
01/2021
1trametinibIBA
01/2021
1Casein Kinase II (Casein Kinase 2)IBA
12/2018
1Karyopherins (Importin)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1Nuclear Pore Complex Proteins (Nucleoporins)IBA
01/2018
1LipidsIBA
11/2016
1lysophosphatidic acidIBA
11/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2016
1XAV939IBA
05/2016
1AngiomotinsIBA
05/2016
1Biomarkers (Surrogate Marker)IBA
05/2016
1TankyrasesIBA
05/2016
1Protein Kinases (Protein Kinase)IBA
03/2016
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2016
1palbociclibIBA
01/2016
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2016
1Gefitinib (Iressa)FDA Link
05/2014
1Radiation-Sensitizing AgentsIBA
04/2014
1Cisplatin (Platino)FDA LinkGeneric
04/2014
1pyrimidineIBA
02/2014
1Sulfhydryl Compounds (Thiols)IBA
03/2013
1Phosphates (Orthophosphate)IBA
03/2013
1GlucuronidesIBA
03/2013
1ON 013105IBA
01/2013
1Rituximab (Mabthera)FDA Link
01/2013
1Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
09/2012
1N- succinimidyl- 3- (4- hydroxyphenyl)propionate (HPPS)IBA
09/2012
1LigandsIBA
09/2012
1ProdrugsIBA
09/2012
1Mitogen-Activated Protein KinasesIBA
09/2012
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
09/2012
1ErbB Receptors (EGF Receptor)IBA
09/2012
1Biological ProductsIBA
12/2011
1Cyclin DIBA
09/2011
1Acetates (Acetic Acid Esters)FDA Link
09/2011
1SodiumIBA
09/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
05/2011
1GTP-Binding Proteins (G-Protein)IBA
04/2011
1Trastuzumab (Herceptin)FDA Link
11/2010

Therapy/Procedure

12Therapeutics
01/2021 - 01/2008
6Drug Therapy (Chemotherapy)
01/2021 - 07/2011
1Aftercare (After-Treatment)
03/2013